Back to results
US 8,278,319 B2Granted
Substituted spiroamine compounds
AssigneeGruenenthal GmbH
InventorsMelanie Reich, Stefan Oberboersch, Stefan Schunk, Ruth Jostock, Sabine Hees, Michael Engels
Life of this patent
Estimating the term…
Abstract
Substituted spiroamine compounds corresponding to the formula (I) In which m, n, o, p, Q, r, s, t, R1, R2, R3, R4a, R4b, R5a, R5b, R6a, R6b, R7, R8, R9, R10 and R11 have defined meanings; a process for the preparation of such compounds, pharmaceutical compositions containing such compounds and the use of substituted spiroamines for the treatment or inhibition of pain and/or other conditions mediated by the bradykinin 1 receptor.
Claims19
A substituted spiroamine compound corresponding to formula (I):
- wherein
- r, s and t each independently represent 0, 1 or 2;
- m, n, o and p each represent 2;
- Q denotes a single bond, —O— or —CH2—;
- R1 denotes CH(aryl)2, aryl, heteroaryl or an aryl or heteroaryl group bonded via a C1-3 alkylene group;
- R2 and R3 are as defined under (i) or (ii):
- (i) R2 denotes H, C1-6 alkyl, C3-8 cycloalkyl, bicyclic 8-12-membered carbocyclyl, CH(aryl)2, aryl or heteroaryl, or
- R2 denotes a C3-8 cycloalkyl, bicyclic 8-12-membered carbocyclyl, CH(aryl)2, aryl or heteroaryl group bonded via a C1-6 alkylene group or C2-6 alkenylene group;
- and
- R3 denotes H, F, Cl, Br, I, —CF3, —OCF3, OH, COOR16, CONR17R18, O—C1-6 alkyl,
- C1-6 alkyl, C3-8 cycloalkyl, aryl or heteroaryl wherein
- R16 denotes C1-6 alkyl;
- R17 and R18 are as defined under (v) or (vi):
- (v) R17 and R18 each independently denote H or C1-6 alkyl;
- or
- (vi) R17 and R18 together with the nitrogen atom linking them form a heterocycle which optionally may be substituted at one or more of its carbon ring members with one or more substituents each independently selected from the group consisting of F, Cl, Br, I, —NH2, —CF3, ═O, —O—CF3, —OH, —SH, —O—C1-6 alkyl, C1-6 alkyl, C3-8 cycloalkyl, aryl and heteroaryl and/or anellated with a saturated, mono- or polyunsaturated or aromatic ring system which optionally may be substituted at one or more of its carbon ring members with one or more substituents each independently selected from the group consisting of F, Cl, Br, I, —NH2, —CF3, ═O, —O—CF3, —OH, —SH, —O—C1-6 alkyl, C1-6 alkyl, C3-8 cycloalkyl, aryl and heteroaryl,
- wherein said heterocycle may be saturated, mono- or polyunsaturated but not aromatic, is 4-,5-,6- or 7-membered, in addition to the N-heteroatom to which R8 and R9 are bound optionally may also contain one or more further heteroatoms or a heteroatom group selected from the group consisting of N, NR19, O, S, S═O and S(═O)2, the ring system is 4-,5-,6- or 7-membered, can contain at least one heteroatom or a heteroatom group selected from the group consisting of N, NR20, O, S, S═O and S(═O)2, wherein
- R19 denotes H, or a C1-6 alkyl, C3-8 cycloalkyl, aryl or heteroaryl group or an aryl, heteroaryl or C3-8 cycloalkyl group bonded via a C1-3 alkylene group, and
- R20 denotes H, or a C1-6 alkyl, C3-8 cycloalkyl, aryl or heteroaryl group, or an aryl, heteroaryl or C3-8 cycloalkyl group bonded via a C1-3 alkylene group;
- or
- R3 denotes a C3-8 cycloalkyl, aryl or heteroaryl group bonded via a C1-6 alkylene group or C2-6 alkenylene group;
- or
- (ii) R2 and R3 together with the —N—(CR4aR4b)r—CH— group linking them form a heterocycle which optionally may be substituted at one or more of its carbon ring members with one or more substituents each independently selected from the group consisting of F, Cl, Br, I, —NH2, —CF3, ═O, —O—CF3, —OH, —SH, —O—C1-6 alkyl, C1-6 alkyl, C3-8 cycloalkyl, aryl and heteroaryl and/or anellated with at least one optionally substituted aryl or heteroaryl,
- wherein said heterocycle may be saturated or mono- or polyunsaturated, but is not aromatic, is 4-, 5-, 6- or 7-membered, and in addition to the N-heteroatom to which R2 is bound optionally may also contain one or more heteroatoms or heteroatom groups independently selected from the group consisting of N, NR12, O, S, S═O or S(═O)2;
- wherein
- R12 denotes H, C1-6 alkyl, —C(═O)—R13, C3-8 cycloalkyl, aryl, heteroaryl or a C3-8 cycloalkyl, aryl or heteroaryl group bonded via a C1-3 alkylene group, and
- R13 denotes C1-6 alkyl, C3-8 cycloalkyl, aryl, heteroaryl or a C3-8 cycloalkyl, aryl or heteroaryl group bonded via a C1-3 alkylene group;
- R4a, R4b, R5a, R5b, R6a and R6b each independently represent H, F, Cl, Br, I, —CF3, —OCF3, OH, SH, O—C1-6 alkyl, C1-6 alkyl, C3-8 cycloalkyl, aryl or heteroaryl;
- or a C3-8 cycloalkyl, aryl or heteroaryl group bonded via a C1-6 alkylene group or C2-6 alkenylene group;
- R7 denotes aryl, heteroaryl or for an aryl or heteroaryl group bonded via a C1-3 alkylene group;
- R8 and R9 are as defined under (iii) or (iv):
- (iii) R8 and R9 each independently denote H, C1-6 alkyl, C2-6 alkenyl, C3-8 cycloalkyl, 3- to 8-membered heterocycloalkyl, aryl or heteroaryl or a C3-8 cycloalkyl, 3- to 8-membered heterocycloalkyl, aryl or heteroaryl group bonded via a C1-3 alkylene group;
- or
- (iv) R8 and R9 together with the nitrogen atom linking them form a heterocycle which optionally may be substituted at one or more of its carbon ring members with one or more substituents each independently selected from the group consisting of F, Cl, Br, I, —NH2, —CF3, ═O, —O—CF3, —OH, —SH, —O—C1-6 alkyl, C1-6 alkyl, C3-8 cycloalkyl, aryl, heteroaryl, C1-3 alkylene-C3-8 cycloalkyl, C1-3 alkylene-aryl and C1-3 alkylene-heteroaryl and/or anellated with a saturated, mono- or polyunsaturated or aromatic ring system which optionally may be substituted at one or more of its carbon ring members with one or more substituents each independently selected from the group consisting of F, Cl, Br, I, —NH2, —CF3, ═O, —O—CF3, —OH, —SH, —O—C1-6 alkyl, C1-6 alkyl, C3-8 cycloalkyl, aryl, heteroaryl, C1-3 alkylene-C3-8-cycloalkyl, C1-3 alkylene-aryl and C1-3 alkylene-heteroaryl,
- wherein said heterocycle may be saturated, mono- or polyunsaturated but not aromatic, is 4-, 5-, 6- or 7-membered, in addition to the N-heteroatom to which R8 and R9 are bound optionally may also contain at least one further heteroatom or a heteroatom group selected from the group consisting of N, NR14, O, S, S═O and S(═O)2, the ring system is 4-, 5-, 6- or 7-membered, can contain at least one heteroatom or a heteroatom group selected from the group consisting of N, NR15, O, S, S═O and S(═O)2;
- wherein
- R14 denotes a group selected from the group consisting of H, C1-6 alkyl, C3-8 cycloalkyl, aryl, heteroaryl or for an aryl, heteroaryl or C3-8 cycloalkyl bonded via a C1-3 alkylene group, and
- R15 denotes a group selected from the group consisting of H, C1-6 alkyl, C3-8 cycloalkyl, aryl, heteroaryl or for an aryl, heteroaryl or C3-8 cycloalkyl bonded via a C1-3 alkylene group;
- and
- R10 and R11 each independently represent 0 to 4 substituents each independently selected from the group consisting of F, OH, C1-6 alkyl, C3-8 cycloalkyl, aryl, heteroaryl and C3-8 cycloalkyl, aryl or heteroaryl group bonded via a C1-6 alkylene group;
- wherein said C1-6 alkyl, C2-6 alkenyl, C1-3 alkylene, C1-6 alkylene, C2-6 alkenylene, carbocyclyl, 3- to 8-membered heterocycloalkyl, C3-8 cycloalkyl, aryl and heteroaryl groups may each be unsubstituted or mono- or polysubstituted with identical or different substituents, and said C1-6 alkyl, C2-6 alkenyl, C1-3 alkylene, C1-6 alkylene and C2-8 alkenylene groups may each be branched or unbranched;
- or a physiologically compatible salt thereof.
39 more elements
Dependencies are inferred from the claim text.